{"id":2348,"date":"2015-06-01T12:08:00","date_gmt":"2015-06-01T10:08:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2015\/so-long-and-thank-you-for-all-the-serotonin"},"modified":"2015-06-01T12:08:00","modified_gmt":"2015-06-01T10:08:00","slug":"so-long-and-thank-you-for-all-the-serotonin","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2015\/so-long-and-thank-you-for-all-the-serotonin","title":{"rendered":"\u201cSo long and thank you for all the serotonin\u201d"},"content":{"rendered":"<p>so lautet \u2013 in Anspielung auf Douglas Adams\u2019 legend\u00e4re Science-Fiction-Kom\u00f6die Hitchhiker\u2019s Guide to the Galaxy \u2013 der Schlusssatz eines lesenswerten, provokanten Editorials des britischen Psychiaters und kritischen Psychopharmakologen David Healy zum Thema Selektive Serotonin-Wiederaufnahme-Hemmer (SSRI; 1). Der Autor hat sich in der Vergangenheit wiederholt kritisch zur Geschichte der Pharmakologie (2) und Themen wie Ghostwriting (vgl. [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>so lautet \u2013 in Anspielung auf Douglas Adams\u2019 legend\u00e4re Science-Fiction-Kom\u00f6die Hitchhiker\u2019s Guide to the Galaxy \u2013 der Schlusssatz eines lesenswerten, provokanten Editorials des britischen Psychiaters und kritischen Psychopharmakologen David Healy zum Thema Selektive Serotonin-Wiederaufnahme-Hemmer (SSRI; 1). Der Autor hat sich in der Vergangenheit wiederholt kritisch zur Geschichte der Pharmakologie (2) und Themen wie Ghostwriting (vgl. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[916,1254,381,4670,378,377],"class_list":["post-2348","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antidepressiva","tag-depression","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin","tag-serotonin-wiederaufnahme-hemmer","tag-ssri"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2348"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2348\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}